
Sign up to save your podcasts
Or
AI has the potential to revolutionize clinical trials in many ways. It could make the development of new treatments faster, safer, cheaper and more personalised. One company in this space is Owkin, a unicorn startup based in Paris. With me is Dr Félix Balazard, Director of
4
44 ratings
AI has the potential to revolutionize clinical trials in many ways. It could make the development of new treatments faster, safer, cheaper and more personalised. One company in this space is Owkin, a unicorn startup based in Paris. With me is Dr Félix Balazard, Director of
11,418 Listeners
3,181 Listeners
8,326 Listeners
439 Listeners
90 Listeners
506 Listeners
5,850 Listeners
6,442 Listeners
782 Listeners
271 Listeners
8,385 Listeners
28,181 Listeners
51 Listeners
178 Listeners
397 Listeners